[Frequency of anti-HBV, CMV, and HTLV antibodies in donors at risk].
From July 1983 to January 1984 (7 months) information on AIDS and high-risk groups was given to each blood donor. A total of 139 subjects out of 136 384 (1.02%) declared to belong to such groups. Their blood donations were reserved to research purpose. Anti-HBc antibody was present in 43 subjects (31 %) in a frequency 6 times superior to what observed in an unselected population. Anti-CMV antibody was detected in 73% of these subjects. Both anti-HBc and anti-CMV antibodies were detected in 28% and were not in 24%. Antibody anti-p24 HTLV was never observed. beta 2 microglobuline was in a normal level in 70 of the 71 tested samples (mean 1.3 mg/l).
D000914:Antibodies, Viral / Q000032:analysis*; D001782:Blood Donors; D003587:Cytomegalovirus / Q000276:immunology*; D017977:Deltaretrovirus / Q000276:immunology*; D004812:Epidemiologic Methods; D006515:Hepatitis B virus / Q000276:immunology*; D006801:Humans; D011795:Surveys and Questionnaires; D001613:beta 2-Microglobulin / Q000032:analysis
D000914:Antibodies, Viral; D001613:beta 2-Microglobulin
Fréquence des anticorps anti-HBV, CMV et HTLV chez les donneurs "à risque."